Press Releases

GlobeNewswire, Inc.

BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient...

GlobeNewswire, Inc.

BRUSSELS, May 19, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) today announced that they have entered into an agreement under which SERB will acquire the exclusive development and...

GlobeNewswire, Inc.

Austin, TX, USA, May 19, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Cholera Vaccine Market Size, Trends and Insights By Type (Whole Cell v. Cholerae O1 with Recombinant B- subunit, Killed Oral O1 and...

GlobeNewswire, Inc.

May 18, 2026 Philips-led consortium selected through Karolinska University Hospital-led Region Stockholm tender to deliver advanced remote monitoring for complex patients Stockholm, Sweden - Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in...

MENAFN

(MENAFN) Swedish health officials have moved to calm public concern over a hantavirus outbreak connected to the cruise ship MV Hondius, saying there is no indication of a wider public health threat or emerging pandemic, according to reports from...

GlobeNewswire, Inc.

WELLESLEY HILLS, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced an upcoming presentation on its...

GlobeNewswire, Inc.

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- Berry Street, the leading metabolic health company transforming nutrition therapy, and Factor, America’s leading ready-to-heat meal delivery service, today announced a new partnership to provide...

EIN Presswire

SamurAI by NTT Security and EARTH 51 bring together senior leaders to address AI governance, resilience and institutional readiness.

EIN Presswire

STOCKHOLM, SWEDEN, May 13, 2026 /⁨EINPresswire.com⁩/ -- Stephen Shaya, M.D., Executive Servant Leader of J&B Medical and Managing Director of Akkad Holdings, was honored during a historic exchange of honors between the Imperial House of Brazil,...

Washington State Office of Attorney General

Washington Attorney General Nick Brown today sued Providence Health & Services in King County Superior Court, alleging that Providence repeatedly failed to provide reasonable accommodations required under state law to pregnant and nursing...

GlobeNewswire, Inc.

In first line, iadademstat with azacitidine and venetoclax continues to show favorable safety and 100% ORR, with a composite complete remission rate (CRc) of 93% (with 79% CR), and an estimated 12-month OS of 74% In FLT3‑mutated...

GlobeNewswire, Inc.

ROCKVILLE, Md. and SUZHOU, China, May 12, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, integrated biopharmaceutical company engaged in the discovery, development and commercialization of...

GlobeNewswire, Inc.

sNDA submission follows agreement with FDA on confirmatory trial, a requirement of the accelerated approval pathway Confirmatory trial designed to demonstrate clinical benefit of mitapivat on reducing transfusion burden in sickle cell disease...

GlobeNewswire, Inc.

Oral presentation of data from RALLY-MF phase 2 trial of DISC-0974 in patients with myelofibrosis and anemia Additional abstracts highlighting updates on HELIOS open label extension study of bitopertin in EPP, EPP LIGHT study (patient survey on...

GlobeNewswire, Inc.

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today...

GlobeNewswire, Inc.

CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated biomarker data...

GlobeNewswire, Inc.

New York, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The sepsis clinical trial analysis report delivers important...

GlobeNewswire, Inc.

– Company unveils first proof-of concept clinical data of AJ1-11095 in patients with myelofibrosis who have been previously treated with a type I JAK2 Inhibitor – NEW YORK and CAMBRIDGE, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- Ajax Therapeutics,...

GlobeNewswire, Inc.

Treatment with BH-30236, a novel CLK inhibitor, was generally well tolerated as monotherapy and in combination with venetoclax Preliminary anti-leukemic activity observed, including patients that were previously treated with venetoclax based...

GlobeNewswire, Inc.

TARPON SPRINGS, Fla., May 8, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway...